Dr. Maria Alva
IMPAQ Papers and Presentations
Wang, G., Daniels, T., Alva, M. L., and Liu, S. (2019, June). Feasibility of Tweets and Social Network Analysis to Study Stakeholders' Interests. Oral presentation at the AcademyHealth Annual Research Meeting, Washington, DC.
Alva, M. L. (2018, June). A Community Based Approach to Increase Consumption of Fruits and Vegetables and Promote Weight Loss among Low Income Children and Individuals with Pre-diabetes in the District of Columbia. Poster presentation at the 7th Conference of the American Society of Health Economists (ASHEcon), Atlanta, GA.
Alva, M. L. (2018, June). Self-reported Health Related Quality of Life as a Predictor of Mortality in Diabetes: The Importance of Heterogeneity. Poster presentation at the 7th Conference of the American Society of Health Economists, Atlanta, GA.
Hoerger, T. J., Romaire, M., Alva, M. L., & Perry, R. (2018, June). Do Financial Incentives for Medicaid Beneficiaries Increase Use of Preventive Services and Lower Expenditures? Evidence from Ten States. Poster presentation at the 7th Conference of the American Society of Health Economists (ASHEcon), Atlanta, GA.
Alva, M. L. (2019). How Much Does Attendance Impact Weight Loss and Health Care Spending in a Diabetes Prevention Program Serving Older Adults? American Journal of Health Promotion, DOI:10.1177/089011711984898.
Liu, S., Laux, M. & Alva, M. (2019, February). Alternatives to Opioids Prescribing Rates Across States: Provider and Beneficiary Characteristics. Poster presentation at the AcademyHealth National Health Policy Conference (NHPC), Washington, DC.
Romaire, M. A., Alva, M. L., Whitman, A. E., Acquah, J. K. & Hoerger, T. J. (2018). Impact of Financial Incentives on Service Use, Spending, and Health in Medicaid. American Journal of Preventive Medicine, 55(6), 875-886.
Thomas, T., Samuel-Hodge, C. D., Porterfield, D. S., Alva, M. L. & Leeman, J. (2018). Scaling Up Diabetes Prevention Programs in North Carolina: Perceptions of Demand From Potential Program Recipients and Providers. The Diabetes Educator, DOI: 10.1177/0145721718811564.
Alva, M., Hoerger, T. J., Zhang, P., & Cheng, Y. J. (2018). State-Level Diabetes-Attributable Mortality and Years of Life Lost in the United States. Annals of Epidemiology, DOI: 10.1016/j.annepidem.2018.08.015.
Alva, M. L., Acquah, J., & Romaire, M. (2018). Impact of financial incentives on diabetes prevention class attendance and program completion: Evidence from Minnesota, Montana, and New York. American Journal of Health Promotion, DOI: 10.1177/0890117118794087.
Whitman, A., Acquah, J., Alva, M., Hoerger, T., & Romaire, M. (2018). Medicaid Incentives for Preventing Chronic Disease: Effects of Financial Incentives for Smoking Cessation. Health Services Research, DOI: 10.1111/1475-6773.12994.
Alva, M., A Review of the Impacts of Different Approaches for Diabetes Prevention and a Framework for Making Investment Decisions. (2018). Int. J. Environ. Res. Public Health.
Alva, M., Hoerger, T., Zhang P., & Gregg, E., (2017, October). Identifying Risk for Type 2 Diabetes in Different Age Cohorts: Does One Size Fit All? BMJ Open Diabetes Research & Care.
Arcaya, M., Coleman, R., Razak, F., Alva, M., & Holman. R. R., (2017, July). Health selection into neighborhoods among patients enrolled in a clinical trial. Preventive Medicine Reports.
Alva, M., Samuel-Hodge, C., Jeyaraman, R., Porterfield, D., Thomas T., & Leeman J., (2017, June) A Feasibility Study of Supply and Demand for Diabetes Prevention Programs in North Carolina. Preventing Chronic Disease.
Alva, M., Hoerger, T., Jeyaraman, R., Amico, P., & Rojas-Smith L., (2017, March). Impact of The YMCA of The USA Diabetes Prevention Program on Medicare Spending and Utilization. Health Affairs 36:3417-424; doi:10.1377/hlthaff.2016.1307.
Alva, M., Gray, A., Mihaylova, B., Leal, J., & Holman, R. R. (2015). The impact of diabetes-related complications on healthcare costs: New results from the UKPDS (UKPDS 84). Diabetic Medicine. doi:10.1111/dme.12647.
Alva, M., Gray, A., Mihaylova, B., & Clarke, P. (2014, April). The effect of diabetes complications on health-related quality of life: The importance of longitudinal data to address patient heterogeneity. Health Economics, 23(4), 487–500.